Does botulinum toxin decrease frequency and severity of sialorrhea in Parkinson's disease?

Journal of the Neurological Sciences

Volumn 253, Issue 1-2, 2007, Pages 85-87

  Nóbrega, Ana Caline ^a   Rodrigues, Bernardo ^a   Torres, Ana Catarina ^a   Enzo, Alfredo ^a   Melo, Ailton ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

Botulinum toxin; Drooling; Parkinson's disease; Sialorrhea

Indexed keywords

BOTULINUM TOXIN A; ENTACAPONE; LEVODOPA; PRAMIPEXOLE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; EDEMA; FEMALE; HUMAN; HYPERSALIVATION; MALE; PARKINSON DISEASE; PAROTID GLAND; PRIORITY JOURNAL; PROGNOSIS; SWALLOWING; TREATMENT OUTCOME; XEROSTOMIA;

AGED; AGED, 80 AND OVER; BOTULINUM TOXIN TYPE A; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; PARKINSON DISEASE; SIALORRHEA; TREATMENT OUTCOME;

EID: 33846579510     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2006.11.015     Document Type: Article

References (11)

1. Friedman A., and Potulska A. Quantitative assessment of parkinsonian sialorrhea and results of treatment with botulinum toxin. Parkinsonism Relat Disord 7 4 (2001) 329-332
2. Porta M., Gamba M., Bertacchi G., and Vaj P. Treatment of sialorrhea with ultrasound guided botulinum toxin type A injection in patients with neurological disoders. J Neurol Neurosurg Psychiatry 70 4 (2001) 538-540
3. Ondo W.G., Hunter C., and Moore W. A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease. Neurology 62 1 (2004) 37-40
4. Crysdale W.S., and White A. Submandibular duct relocation for drooling: a 10-year experience with 194 patients. Otolaryngol Head Neck Surg 101 (1989) 87-92
5. Mancini F., Zangaglia R., Cristina S., Sommaruga M.G., Martignoni E., Nappi G., et al. Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in Parkinsonism. Mov Disord 18 6 (2003) 685-688
6. Pal P.K., Calne D.B., Calne S., and Tsui J.K.C. Botulinum toxin A as treatment for drooling saliva in Parkinson's disease. Neurology 54 (2000) 244-247
7. Contarino MF, Pompili M, Tittoto P, Vanacore N, Sabatelli M, Cedrone A, et al. Botulinum toxin B ultrasound-guided injections for sialorrhea in amyotrophic lateral sclerosis and Parkinson's disease. Parkinsonism Relat Disord, published online 27 June 2006, doi:10.1016/j.parkreldis.2006.05.005.
8. Suskind D.L., and Tilton A. Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy. Laryngoscope 112 1 (2002) 73-81
9. Dogu O., Apaydin D., Sevin S., Talas D.U., and Aral M. Ultrasound-guided versus blind intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson's disease. Clin Neurol Neurosurg 106 2 (2004) 93-96
10. Jost W.H. Treatment of drooling in Parkinson's disease with botulinum toxin. Mov Disord 14 6 (1999) 1057
11. Racette B.A., Good L., Sagitto S., and Perlmuter J.S. Botulinum toxin B reduces sialorrhea in parkinsonism. Mov Disord 18 9 (2003) 1059-1061